Tolero Pharmaceuticals, Inc. - Product Pipeline Review - 2016

  • ID: 3641063
  • Company Profile
  • 35 pages
  • Global Markets Direct
1 of 4
Tolero Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Summary

‘Tolero Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Tolero Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Tolero Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Tolero Pharmaceuticals, Inc.
- The report provides overview of Tolero Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Tolero Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Tolero Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Tolero Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Tolero Pharmaceuticals, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Tolero Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Tolero Pharmaceuticals, Inc. Snapshot

Tolero Pharmaceuticals, Inc. Overview

Key Information

Key Facts

Tolero Pharmaceuticals, Inc. - Research and Development Overview

Key Therapeutic Areas

Tolero Pharmaceuticals, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Tolero Pharmaceuticals, Inc. - Pipeline Products Glance

Tolero Pharmaceuticals, Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Tolero Pharmaceuticals, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Tolero Pharmaceuticals, Inc. - Drug Profiles

alvocidib hydrochloride

Product Description

Mechanism of Action

R&D Progress

HCI-1680

Product Description

Mechanism of Action

R&D Progress

HCI-1708

Product Description

Mechanism of Action

R&D Progress

SGI-7079

Product Description

Mechanism of Action

R&D Progress

TP-0158

Product Description

Mechanism of Action

R&D Progress

TP-0184

Product Description

Mechanism of Action

R&D Progress

TP-0413

Product Description

Mechanism of Action

R&D Progress

TP-0903

Product Description

Mechanism of Action

R&D Progress

TP-1101

Product Description

Mechanism of Action

R&D Progress

TP-3654

Product Description

Mechanism of Action

R&D Progress

Tolero Pharmaceuticals, Inc. - Pipeline Analysis

Tolero Pharmaceuticals, Inc. - Pipeline Products by Target

Tolero Pharmaceuticals, Inc. - Pipeline Products by Route of Administration

Tolero Pharmaceuticals, Inc. - Pipeline Products by Molecule Type

Tolero Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action

Tolero Pharmaceuticals, Inc. - Recent Pipeline Updates

Tolero Pharmaceuticals, Inc. - Dormant Projects

Tolero Pharmaceuticals, Inc. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

SGI-1776

Tolero Pharmaceuticals, Inc. - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Tolero Pharmaceuticals, Inc., Key Information

Tolero Pharmaceuticals, Inc., Key Facts

Tolero Pharmaceuticals, Inc. - Pipeline by Indication, 2016

Tolero Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016

Tolero Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016

Tolero Pharmaceuticals, Inc. - Phase II, 2016

Tolero Pharmaceuticals, Inc. - Preclinical, 2016

Tolero Pharmaceuticals, Inc. - Pipeline by Target, 2016

Tolero Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016

Tolero Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016

Tolero Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016

Tolero Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016

Tolero Pharmaceuticals, Inc. - Dormant Developmental Projects,2016

Tolero Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016

List of Figures

Tolero Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016

Tolero Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016

Tolero Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016

Tolero Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2016

Tolero Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016

Tolero Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016

Tolero Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll